Panacea Life Sciences Holdings, Inc. Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers into Level 3
Panacea Life Sciences Holdings, Inc. (PLSH) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers into Level 3 of $469.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3 · last filed 2019-03-29
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers into level 3 for fiscal 2018 was $469.00K, a 46.46% decline from fiscal 2017.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers into level 3 for fiscal 2017 was $876.00K.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers into Level 3 12 month |
|---|---|
| 2018-12-31 | $469.00K 10-K · filed 2019-03-29 |
| 2017-12-31 | $876.00K 10-K · filed 2019-03-29 |